We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More informationAccept
A EUROPEAN LEADER IN PHARMACEUTICAL PRODUCTS FOR THE CENTRAL NERVOUS SYSTEM (CNS)
With a unique understanding of the CNS market for over 35 years, Neuraxpharm develops and commercializes established brands, value added medicines, generics, Consumer Healthcare products, medical cannabis, beyond-the-pill solutions (digital health and medical devices) and orphan drugs.
We are continuously striving to offer a wide range of effective, high quality and affordable CNS treatment options in Europe.
Neuraxpharm manufactures many of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain.
NEURAXPHARM, SPECIALIZED IN CNS SINCE 1985
NEURAXPHARM GROUP
Neuraxpharm develops and markets CNS pharmaceuticals related to the prevention of CNS indications in Europe's main countries
B2B solutions provider dedicated to the development and manufacturing of finished dosage forms (FDFs)
The consolidation of all the companies within Neuraxpharm allows us to establish growth and cross-business operational synergies in strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion